Medication info
Amosar Tablet 5/100mg

Amosar Tablet 5/100mg

Prescription medicationTablet
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Hawon's Pharmaceutical Co., Ltd.
Appearance
Light pink rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502690 · Approved 2015.04.30 · Insurance code 651503690

Summary

Main use
Treatment of hypertension not controlled with monotherapy or requiring initial combination therapy
Who uses it
Adults · Children
Adult dosage
The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before administering this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, an immediate switch to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with decreased effective intravascular volume: Administration of this medicine is not recommended in the small number of patients with decreased effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For patients aged 75 years and older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
Children's dosage
Pediatric patients aged 18 years and younger: The safety and efficacy have not been established; therefore, use of this medicine is not recommended.

Ingredients

Manufacturer
Hawon's Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension not controlled with monotherapy or requiring initial combination therapy

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with single therapy of amlodipine or losartan. Furthermore, it is applicable for initial treatment in stage 2 hypertension patients who require combination therapy to reach their target blood pressure. This medicine effectively lowers blood pressure to assist in hypertension management.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 1 tablet once daily, taken with water with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before administering this medicine. However, if blood pressure is not controlled with monotherapy using an individual component, an immediate switch to this medicine may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with the combination product compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with decreased effective intravascular volume: Administration of this medicine is not recommended in the small number of patients with decreased effective intravascular volume (e.g., patients receiving treatment with high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For patients aged 75 years and older, an initial dose of losartan of 25 mg once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.

Children's dosage

Pediatric patients aged 18 years and younger: The safety and efficacy have not been established; therefore, use of this medicine is not recommended.

Precautions

This medication can cause serious injury or death to the fetus when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. It may also pose risks to the fetus in early pregnancy; therefore, women of childbearing potential should consult prior to administration. Patients with low blood volume or those taking diuretics may experience a sudden drop in blood pressure when initially using this medication, and caution is advised. Patients with hypersensitivity to the components of this medication, pregnant or breastfeeding women, those with severe liver dysfunction, severe aortic stenosis, or in a state of shock must not take this medication. Patients with reduced blood volume, renal impairment, or hyperkalemia must use this medication with caution, and regular testing may be necessary. Dizziness or drowsiness may occur while using this medication, so it is advisable to avoid dangerous machinery operation or driving. This medication lowers blood pressure; therefore, if taken with other antihypertensive medications, the effects may be enhanced, and should be taken according to a doctor's instructions. Grapefruit juice may excessively increase the effects of this medication, so it is advisable not to consume it together. During pregnancy or breastfeeding, this medication should not be taken due to risks to the fetus and newborn, and it should be avoided while breastfeeding as well. In case of overdose, severe hypotension and arrhythmias may occur, and if suspected, medical attention should be sought immediately. It is not recommended for children or adolescents under 18 years of age due to lack of established safety and efficacy. Elderly patients, especially those over 75 years old, should consult a specialist for appropriate dosing adjustments. Patients with impaired liver or kidney function may need to adjust the dosage or avoid administration, and should consult healthcare professionals. Store this medication safely out of reach of children and avoid transferring it to other containers.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb hypoxia
  • craniofacial malformation
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 198 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival hyperemia
  • polyuria
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension elevation
  • sensory reduction
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • ageusia
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • vascular edema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • hypotension
  • sinus block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin erythema
  • maculopapular rash
  • tinnitus
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • limb pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • diarrhea
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • vascular edema
  • skin exfoliation phenomenon
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory diminution
  • decreased libido
  • memory impairment
  • migraine
  • neural hyperexcitability
  • panic disorder
  • sleep disorders
  • tremors
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • hair loss
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • eye burning
  • joint pain
  • conjunctivitis
  • taste distortion
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • urethral infection
  • liver function abnormalities
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • ageusia
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • elevated serum creatinine
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should maintain room temperature between 1 degree and 30 degrees Celsius to help prolong the effectiveness of the medication.

Appearance and packaging

Appearance

Light pink rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.